A T164S mutation in the dengue virus NS1 protein is associated with greater disease severity in mice. Chan KWK, Watanabe S, Jin JY, Pompon J, Teng D, Alonso S, Vijaykrishna D, Halstead SB, Marzinek JK, Bond PJ, Burla B, Torta F, Wenk MR, Ooi EE, Vasudevan SG. Sci Transl Med. 2019 Jun 26;11(498). pii: eaat7726. doi: 10.1126/scitranslmed.aat7726.
Chacko AM, Watanabe S, Herr KH, Kalimuddin S, Tham JY, Ong J, Reolo M, Serrano R, Cheung YB, Low JG and Vasudevan SG (2017) 18F-FDG as an Inflammation Biomarker for Imaging Dengue Virus Infection and Treatment. J Clin. Investigations Insight 4;2(9). pii: 93474.
Tay MY, Smith K, Ng IH, Chan KW, Zhao Y, Ooi EE, Lescar J, Luo D, Jans DA, Forwood JK, Vasudevan SG. (2016) The C-terminal 18 Amino Acid Region of Dengue Virus NS5 Regulates its Subcellular Localization and Contains a Conserved Arginine Residue Essential for Infectious Virus Production. PLoS Pathogens 12(9):e1005886.
Zhao, Y., Soh, T. S., Zheng, J., Chan, K. W. K., Phoo, W. W., Lee, C. C., Tay, M. Y. F., Swaminathan, K., Cornvik, T. C., Lim, S. P., Shi, P. Y., Lescar, J., Vasudevan, S. G., Luo, D. (2015). A crystal structure of the dengue virus NS5 protein reveals a novel inter-domain interface essential for protein flexibility and virus replication. PLoS Pathogens, 11(3), e1004682.
Zhao, Y., Soh, T. S., Chan, K. W. K., Fung, S. S. Y., Swaminathan, K., Lim, S. P., Shi, P-Y., Huber, T., Lescar, J., Luo, D., Vasudevan, SG (2015). Flexibility of NS5 Methyltransferase-Polymerase Linker Region Is Essential for Dengue Virus Replication. Journal of Virology, 89(20), 10717-10721.
Watanabe, S., Chan, K. W. K., Wang, J., Rivino, L., Lok, S. M., Vasudevan, SG (2015). Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice. Journal of Virology, 89(11), 5847-5861.
Low, J. G., Sung, C., Wijaya, L., et al., Vasudevan, S. G. (2014). Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. The Lancet Infectious Diseases, 14(8), 706-715.
Schul, W., Liu, W., Xu, H. Y., Flamand, M., Vasudevan, S. G. (2007). A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. Journal of Infectious Diseases, 195(5), 665-674.
Fink, J., Gu, F., Ling, L., Tolfvenstam, T., Olfat, F., Chin, K. C., Aw, P., George, G., Kuznetsov, V. A., Schreiber, M., Vasudevan, S. G., Hibberd, M. L. (2007). Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Neglected Tropical Diseases, 1(2), e86.
Yap, T. L., Xu, T., Chen, Y. L., Malet, H., Egloff, M. P., Canard, B., Vasudevan, S. G., Lescar, J. (2007). Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution. Journal of Virology, 81(9), 4753-4765.
Erbel, P., Schiering, N., D'Arcy, A., Renatus, M., Kroemer, M., Lim, S. P., Yin, Z., Keller, T. H., Vasudevan, S. G., Hommel, U. (2006). Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nature Structural & Molecular Biology, 13(4), 372-373.